This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

82/100

✓ Peer-reviewed alzhub usefulness score 82 out of 100. Costs and economics

Topic: Health services, long-term care and technology

The crude incidence rate was 16 (CI: 13-20) cases per 1,000 person-years (pyr) with 17 (CI: 12-21) per 1,000 pyr for females and 14 (CI: 9-21) per 1,000 pyr for males. Based on this incidence, we project an estimation of 220,632 new cases in 2030, 295,066 in 2040, and 378,461 in 2050. Disease burden was at 2,876 DALYsper 100,000 persons. The economic burden per patient was around Php 196,000 annually (i.e., ~4,070 USD, or 36.7% of average family annual income in the Philippines). The majority (86.29%) of this care expense was indirect cost attributed to estimated lost potential earning of unpaid family caregivers whereas direct medical cost accounted for only 13.48%. We provide the first Filipino community-based data on the incidence of dementia, DALYs, and cost of care to reflect the epidemiologic and economic impact of disease. The findings of this study serve to guide the development of a national dementia plan.

Key findings

The crude incidence rate was 16 (CI: 13-20) cases per 1,000 person-years (pyr) with 17 (CI: 12-21) per 1,000 pyr for females and 14 (CI: 9-21) per 1,000 pyr for males.
Based on this incidence, we project an estimation of 220,632 new cases in 2030, 295,066 in 2040, and 378,461 in 2050.
Disease burden was at 2,876 DALYsper 100,000 persons.
The economic burden per patient was around Php 196,000 annually (i.e., ~4,070 USD, or 36.7% of average family annual income in the Philippines).
The majority (86.29%) of this care expense was indirect cost attributed to estimated lost potential earning of unpaid family caregivers whereas direct medical cost accounted for only 13.48%.

New to this subject? Start with our plain-English guide: Costs & economics →

Study details

Study designmeta-analysis
Participants748
Effect sizeor 36.7; 86.29%; 13.48%
Evidence strengthHigh

How this study scored 82/100

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multi-centre collaboration and free to read, so those were left out: it earned 46 of the 56 points we could judge it on, which is 82 out of 100.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Frontiers in public health)
Journal's citation record	— / 4	No journal record from OpenAlex — left out of this score
Study design	12 / 12	A meta-analysis pooling many studies
Strength of evidence	5 / 5	Rated “high” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	3 / 5	2021 — within 6 year(s) of the newest study here
Sample size	2 / 4	748 participants
Effect reported	2 / 3	Effect reported as a number, without an interval or test
Studied in people	3 / 3	Studied in people (participant count stated)
Randomised / blinded	0 / 2	A review of other studies — randomisation is not credited here
Times cited	— / 7	No citation count (not found in OpenAlex) — left out of this score
Citations per year	— / 5	No citation count or no year — left out of this score
Impact for its field and year	— / 6	No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here	— / 6	Not yet checked against this library's citation graph — left out of this score
Still being cited	— / 4	No yearly citation counts — left out of this score
Senior author's track record	— / 4	Senior author's record not available — left out of this score
Institution's track record	— / 3	No institution listed in OpenAlex — left out of this score
Multi-centre collaboration	— / 3	Institutions not listed — left out of this score
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 34055712)
Free to read	— / 2	Access not recorded — left out of this score
Points	46 / 56	Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 46 of the 56 points we could judge it on is 82 out of 100.
Total	82 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Dominguez, J., Jiloca, L., Fowler, K. C., De Guzman, M. F., Dominguez-Awao, J. K., Natividad, B., et al. (2021). Dementia Incidence, Burden and Cost of Care: A Filipino Community-Based Study. Frontiers in public health. https://doi.org/10.3389/fpubh.2021.628700

Vancouver

Dominguez J, Jiloca L, Fowler KC, De Guzman MF, Dominguez-Awao JK, Natividad B, et al. Dementia Incidence, Burden and Cost of Care: A Filipino Community-Based Study. Frontiers in public health. 2021. doi:10.3389/fpubh.2021.628700. PMID: 34055712.

BibTeX

@article{dominguez2021-34055712,
  author  = {Dominguez, Jacqueline and Jiloca, Leo and Fowler, Krizelle Cleo and De Guzman, Ma Fe and Dominguez-Awao, Jhozel Kim and Natividad, Boots and Domingo, Jeffrey and Dominguez, Jayvee Dyne and others},
  title   = {{Dementia Incidence, Burden and Cost of Care: A Filipino Community-Based Study}},
  journal = {Frontiers in public health},
  year    = {2021},
  doi     = {10.3389/fpubh.2021.628700},
  pmid    = {34055712},
  url     = {https://doi.org/10.3389/fpubh.2021.628700}
}

Related studies in Costs and economics

Similar studies

More on Costs and economics

See all studies in Costs and economics →